Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × Thalidomide × Clear all

NCT00971126 2016-05-04

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT00155272 2005-09-12

Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular